—
C+
C+ The full Closelook — membership. Open the C+ overview

Sarepta Therapeutics Inc (SRPT) — Technical state

As of 2026-09-18 — re-computed nightly across the coverage universe. Closelook diary readings, not advice.

Recovery attempt under the 200-day

Trades +8.4% vs the 50-day and +4.4% vs the 200-day average, 20.6% below the 52-week high and +37% off the 52-week low; a death cross printed 72 sessions ago. Computed from daily closes.

The moving-average stack

Continue: the SRPT chart & overview · the signal board

FAQ · from the current data · as of 2026-09-18

Quick answers

What is the current Closelook signal on SRPT?

Recovery attempt under the 200-day — Trades +8.4% vs the 50-day and +4.4% vs the 200-day average, 20.6% below the 52-week high and +37% off the 52-week low; a death cross printed 72 sessions ago. Computed from daily closes. As of 2026-09-18; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is SRPT above its 50-day and 200-day moving averages?

As of 2026-09-18, Sarepta Therapeutics Inc trades +8.4% above its 50-day and +4.4% above its 200-day average, with the 20-day -3.1% away.

How far is SRPT from its 52-week high?

20.6% below the 52-week high and 37% above the 52-week low, as of 2026-09-18.

Related in the Closelook universe

then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.